---
figid: PMC7873600__fonc-10-539527-g002
figtitle: Combination of targeted therapy with immunotherapy or chemotherapy in bladder
  cancer
organisms:
- NA
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
pmcid: PMC7873600
filename: fonc-10-539527-g002.jpg
figlink: pmc/articles/PMC7873600/figure/f2/
number: F2
caption: Combination of targeted therapy with immunotherapy or chemotherapy in bladder
  cancer. FGFR and PI3K/AKT/mTOR signing pathways are potential targets in bladder
  cancer. Blocking FGFR or PI3K/AKT/mTOR pathway decreased PD-L1 levels and increased
  immunotherapy response. On the other hand, these targeted drugs increased the pro-apoptotic
  effect and cytotoxic effect of chemotherapy drugs.
papertitle: Novel Combination Therapies for the Treatment of Bladder Cancer.
reftext: Mei Peng, et al. Front Oncol. 2020;10:539527.
year: '2020'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9573104
figid_alias: PMC7873600__F2
figtype: Figure
redirect_from: /figures/PMC7873600__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7873600__fonc-10-539527-g002.html
  '@type': Dataset
  description: Combination of targeted therapy with immunotherapy or chemotherapy
    in bladder cancer. FGFR and PI3K/AKT/mTOR signing pathways are potential targets
    in bladder cancer. Blocking FGFR or PI3K/AKT/mTOR pathway decreased PD-L1 levels
    and increased immunotherapy response. On the other hand, these targeted drugs
    increased the pro-apoptotic effect and cytotoxic effect of chemotherapy drugs.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - btl
  - htl
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Akt
  - Mtor
  - Tor
  - FGFR1
  - FGFR2
  - FGFR3
  - FGFR4
  - FGFRL1
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - AKT1
  - AKT2
  - AKT3
  - CD274
  - MTOR
  - tyrosine
  - Everolimus
---
